share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

SEC announcement ·  Feb 29 06:18
Summary by Futu AI
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 02/27/2024, did not specify the number of shares traded or the transaction price. As a result, the total value of the shares and the number of shares held after the action remain undisclosed. This announcement is part of the standard disclosure requirements for executives and may be of interest to investors monitoring insider activities within Pfizer.
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 02/27/2024, did not specify the number of shares traded or the transaction price. As a result, the total value of the shares and the number of shares held after the action remain undisclosed. This announcement is part of the standard disclosure requirements for executives and may be of interest to investors monitoring insider activities within Pfizer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.